Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma?
Gynecologic oncology, 2012-04, Vol.125 (1), p.94-98
2012
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Identifying gynecologic oncology patients with high symptom burden
Gynecologic oncology, 2015-04, Vol.137, p.195-195
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Provision of “primary palliative care” by gynecologic oncologists
Gynecologic oncology, 2015-04, Vol.137, p.52-52
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A prospective phase II trial of the listeria-based human papillomavirus immunotherpay axalimogene filolisbac in second- and third-line metastatic cervical cancer: A NRG oncology group trial
Gynecologic oncology, 2017-06, Vol.145, p.220-220
2017
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Clinical implications for MSI, MLH1 methylation analysis and IHC in Lynch screening for endometrial cancer patients: An analysis of 940 endometrioid endometrial cancer cases from the GOG 0210 study
Gynecologic oncology, 2015-04, Vol.137, p.4-5
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Impact of circulating tumor cells (CTCs) on overall survival among patients treated with chemotherapy plus bevacizumab for advanced cervical cancer: An NRG Oncology/Gynecologic Oncology Group study
Gynecologic oncology, 2015-04, Vol.137, p.12-12
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
High-risk patients with recurrent/advanced cervical cancer may derive the most benefit from antiangiogenesis therapy: A Gynecologic Oncology Group (GOG) study
Gynecologic oncology, 2014-06, Vol.133, p.60-60
2014
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Prospective validation of pooled clinical prognostic factors in patients with recurrent and advanced cervical cancer: A Gynecologic Oncology Group (GOG) study
Gynecologic oncology, 2014-06, Vol.133, p.59-60
2014
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Patient and physician factors associated with participation in Gynecologic Oncology Group (GOG) trials in cervical and uterine cancer
Gynecologic oncology, 2014-06, Vol.133, p.39-40
2014
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase II trial of vaginal cuff brachytherapy followed by dose-dense chemotherapy in early-stage endometrial cancer patients with enriched, high-intermediate risk factors for recurrence
Gynecologic oncology, 2020-10, Vol.159, p.242-242
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Cervical cancer outcomes in true cut through simple hysterectomy compared to appropriately managed controls
Gynecologic oncology, 2019-06, Vol.154, p.113-113
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Catheter-Related Complications of Intraperitoneal Chemotherapy as First-Line Treatment for Advanced Epithelial Ovarian Carcinoma
Gynecologic oncology, 2007-11, Vol.107 (2), p.368-369
2007
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
VP2-2023: Dostarlimab+chemotherapy for the treatment of primary advanced or recurrent (A/R) endometrial cancer (EC): A placebo (PBO)-controlled randomised phase III trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Annals of oncology, 2023-05, Vol.34 (5), p.500-501
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
Gynecologic oncology, 2022-07, Vol.166 (1), p.44-49
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A phase IB trial of paclitaxel and carboplatin + galunisertib in patients with uterine and ovarian carcinosarcoma
Gynecologic oncology, 2020-10, Vol.159, p.23-23
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Advanced Ovarian Cancer: Is Cure a Reasonable Expectation?
Gynecologic oncology, 2007-11, Vol.107 (2), p.371-371
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Stage IVb Endometrial Cancer: Does Applying an Ovarian Cancer Treatment Paradigm Result in Similar Outcomes?
Gynecologic oncology, 2007-11, Vol.107 (2), p.368-368
2007
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial
Annals of oncology, 2024-08, Vol.35 (8), p.728-738
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Multiple Factor IIIA Endometrial Cancer is a Marker of Poor Prognosis
Gynecologic oncology, 2007-11, Vol.107 (2), p.372-372
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Adjuvant Chemotherapy for the “Oldest Old” Ovarian Cancer Patients: Self-Reported and Objective Toxicities
Gynecologic oncology, 2007-11, Vol.107 (2), p.379-380
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Stage IIIC Endometrial Cancer Should be Further Stratified
Gynecologic oncology, 2007-11, Vol.107 (2), p.371-372
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Nodal Distribution in Node Positive Endometrial Cancer
Gynecologic oncology, 2007-11, Vol.107 (2), p.372-373
2007
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study
International journal of gynecological cancer, 2020-05, Vol.30 (5), p.596-601
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
37MO Dostarlimab plus chemotherapy in primary advanced or recurrent endometrial cancer (pA/rEC) in the RUBY trial: Overall survival (OS) by MMR status and molecular subgroups
ESMO open, 2024-06, Vol.9, p.103537, Article 103537
2024
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Final Overall Survival Analysis of the Phase III Randomized Trial of Chemotherapy with and Without Bevacizumab for Advanced Cervical Cancer: a Nrg Oncology - Gynecologic Oncology Group Study
Annals of oncology, 2014-09, Vol.25, p.v1
2014
Volltextzugriff (PDF)
1 – 25 von 29
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen